Skip to main content
SpringerLink
Log in

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population

  • Original paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Gliomas are the most common primary brain tumors in India. The main epigenetic modification in glioma is aberrant DNA methylation that is now renowned to be a common hallmark of brain tumors. This study was designed to determine the frequency of aberrant CpG island methylation in the promoter regions of p21 and p73 in different grades of glioma and to explore their respective chromosomal aberrations. Total of 160 patients with histologically confirmed grades of glioma (I, II, III, and IV) were included in the study. DNA samples from blood and brain tissues, including benign lesions were subjected to sodium bisulfite conversion and hypermethylation detection using methylation-specific PCR followed by RT–PCR. Western blotting was also carried out for p21 and its related protein, p53. A total of 124 of 160 glioma samples (77.5%) displayed CpG island hypermethylation of both p73, p21 genes associated with the loss of mRNA expression (P < 0.001) and the loss of protein expressions (p53 independent p21 expression). p73 gene showed increased methylation frequency in all grades, 40 of 60 (66%) glioblastomas and 16 of 30 (53.3%) anaplastic astrocytoma, 10 of 20(50%) oligodendrogliomas, 8 of 20 (40%) ependymoma, and low-grade glioma 6 of 20 (30%). The percentage of methylation significantly well correlated with the overall survival and also with chromosomal loss. Thus, the studied glioma patients among south Indians showed a high frequency of aberrant methylation with varied chromosomal signatures in different grades, playing a role in aggressiveness and characterization of a particular grade, the appreciation of which might help for designing a specific therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetic joins genetics. Trends Genet. 2000;16:168–74.

    Article  PubMed  CAS  Google Scholar 

  2. Esteller M, Corn PG, Baylin SB, Herman JG. Gene hypermethylation profile of human cancer. Cancer Res. 2001;61:3225–9.

    PubMed  CAS  Google Scholar 

  3. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol. 2004;10:3441–54.

    PubMed  CAS  Google Scholar 

  4. Phatak P, Selvi SK, Divya T, Hegde AS, Hegde S, Somasundaram K. Alterations in tumor suppressor gene p53 in human gliomas from Indian patients. J Bio Sci. 2002;27:673–8.

    CAS  Google Scholar 

  5. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, epidemiology, and end results (SEER) data. J Neurosurg. 1991;88:1–10.

    Google Scholar 

  6. Lonso ME, Bello MJ, Lomas J, Gonzalez-Gomez P, Arjona D, De Campos JM, et al. Absence of mutation of the p73 gene in astrocytic neoplasms. Int J Oncol. 2001;19:609–12.

    Google Scholar 

  7. Corn PG, Kuerbitz SJ, Van noesel MM, Esteller M, Compitello N, Baylin SB, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt’s lymphoma is associated with 5’ CpG island methylation. Cancer Res. 1999;59:3352–6.

    PubMed  CAS  Google Scholar 

  8. Zhu J, Jiang J, Zhou W, Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 1998;58:5061–5.

    PubMed  CAS  Google Scholar 

  9. Kamiya M, Nakazato Y. The expression of p73, p21 and MDM2 proteins in gliomas. Neuro Oncol. 2002;59:143–9.

    Article  Google Scholar 

  10. Kleihues P, Cavenee WK. Pathology and Genetics of Tumors of the Nervous System World Health Organization Classification of Tumors.  : IARC Press; 2000.

    Google Scholar 

  11. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25.

    PubMed  Google Scholar 

  12. Rey JA, Bello MJ, Jimenez-Lara A, Vaquero J, Kusak ME, de Campos JM, et al. Loss of heterozygosity for distal markers on 22q in human glioma. Int J Cancer. 1992;51:703–6.

    Article  PubMed  CAS  Google Scholar 

  13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821–6.

    Article  PubMed  CAS  Google Scholar 

  14. Banelli B, Casciano I, Romani M. Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene. 2000;19:4553–6.

    Article  PubMed  CAS  Google Scholar 

  15. Staalesen V, Leirvaag B, Lillehaug JR, Lonning PE. Genetic and epigenetic changes in p21 and p21B do not correlate with Resistance to doxorubicin or mitomycin and 5-fluorouracil in locally advanced breast cancer. Clin Cancer Res. 2004;15:3438–43.

    Article  Google Scholar 

  16. Paluszczak J, Baer-Dubowska W. Epigenetic diagnostics of cancer–the application of DNA methylation markers. J Appl Genet. 2006;47:365–75.

    Article  PubMed  Google Scholar 

  17. Esteller M. Cancer epigenetic. DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol. 2003;532:39–49.

    Article  PubMed  CAS  Google Scholar 

  18. Esteller M, Corn PG, Baylin SB, Herman JG. Gene hypermethylation profile of human cancer. Cancer Res. 2001;61:3225–9.

    PubMed  CAS  Google Scholar 

  19. Ichimura K, Vogazianou AP, Liu L, Pearson DM, Bäcklund LM, Plant K, et al. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene. 2008;27:97–108.

    Article  Google Scholar 

  20. Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, et al. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A. J Neurosurgery. 2007;107:398–404.

    Article  CAS  Google Scholar 

  21. Nakamura M, Yang F, Fujisawa H, Yonekawa Y, Kleihues P, Ohgaki H. Loss of heterozygosity on chromosome19 in secondary glioblastomas. J Neuropathol Exp Neurol. 2000;59:539–43.

    PubMed  CAS  Google Scholar 

  22. Watanabe T, Nakamura M, Yonekawa Y, Kleihues P, Ohgaki H. Methylation of the p73gene in gliomas. Acta Neuropathol. 2002;104:357–62.

    PubMed  CAS  Google Scholar 

  23. Bohnke A, Westphal F, Schmidt A, El-Awady R, Dahm-Daphi J. Role of p53 mutations, protein function and DNA damage for the radio sensitivity of human tumour cells. Int J Radiat Biol. 2004;21:362–409.

    Google Scholar 

  24. Lxohrum MA, Vousden KH. Regulation and function of the p53-related proteins: same family, different rules. Trends Cell Biol. 2000;10:197–202.

    Article  Google Scholar 

  25. Schwab M, Praml C, Amler L. Genomic instability in 1p and human malignancies. Genes Chromosom Cancer. 1996;16:211–29.

    Article  PubMed  CAS  Google Scholar 

  26. Bello MJ, Leone PE, Nebreda P. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet. 1995;83:160–4.

    Article  PubMed  CAS  Google Scholar 

  27. Von Deimling A, Fimmers R, Schmidt MC, Bender B, Fassbender F, Nagel J, et al. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors. J Neuropathol Exp Neurol. 2000;59:544–58.

    Google Scholar 

  28. Yu J, Zhang H, Gu J, Lin S, Li J, Lu W, et al. Methylation profiles of thirty-four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer. 2004;4:65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, University of Madras, Guindy Campus, Chennai, 25, Tamilnadu, India

    Mahalakshmi Palani, Sabarinathan Devan & A. J. Vanisree

  2. Director, Institute of Neurology and Neurosurgery, Madras Medical College, Chennai, 20, Tamilnadu, India

    R. Arunkumar

Authors
  1. Mahalakshmi Palani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabarinathan Devan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Arunkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. J. Vanisree
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. J. Vanisree.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palani, M., Devan, S., Arunkumar, R. et al. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population. Med Oncol 28 (Suppl 1), 445–452 (2011). https://doi.org/10.1007/s12032-010-9671-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9671-4

Keywords

Search

Navigation